The assessment of PTEN tumor suppressor gene in combination with Gleason scoring and serum PSA to evaluate progression of prostate carcinoma-Reference-Cited by-同舟云学术

The assessment of PTEN tumor suppressor gene in combination with Gleason scoring and serum PSA to evaluate progression of prostate carcinoma

Published:2004-07 Issue:4 Volume:22 Page:307-312
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Koksal Ismail Turker,Dirice Ercument,Yasar Duygu,Sanlioglu Ahter D,Ciftcioglu Akif,Gulkesen Kemal H,Ozes Nidai O,Baykara Mehmet,Luleci Guven,Sanlioglu Salih

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference25 articles.

1. Molecular basis of co-targeting prostate tumor and stroma;Yeung;J Cell Biochem Suppl,2002

2. Prostate cancer;Devi;Curr Opin Mol Ther,2002

3. Trends in poorly differentiated prostate cancer 1973 to 1994;Perrotti;J Urol,1998

4. Prognostic markers in prostate cancer;Ross;Expert Rev Mol Diagn,2002

5. Morphologic and molecular prognostic markers in prostate cancer;Ross;Adv Anat Pathol,2002

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tissue-Based Biomarkers for the Risk Stratification of Men With Clinically Localized Prostate Cancer;Frontiers in Oncology;2021-05-28

2. Clinical Actionability of the Genomic Landscape of Metastatic Castration Resistant Prostate Cancer;Cells;2020-11-17

3. The Role of the Latest Biomarkers, the Gleason Tertiary Index, and Comorbid Status in Improving the Detection of High-risk Hormone-untreated Non-metastatic Prostate Cancer;Health of Man;2020-06-30

4. PTEN Loss in a Prostate Cancer Cohort From Jordan;Applied Immunohistochemistry & Molecular Morphology;2020-05

5. The correlation of ESCO1 expression with a prognosis of prostate cancer and anti-tumor effect of ESCO1 silencing;Translational Cancer Research;2019-06